The changing face of corporate venturing in biotechnology

被引:0
|
作者
Georg von Krogh
Boris Battistini
Fotini Pachidou
Pius Baschera
机构
[1] Technology and Economics at ETH Zurich.,Georg von Krogh is chair of strategic management and innovation in the Department of Management
[2] Boris Battistini is a research associate at ETH Zurich and project leader of the Corporate Venturing Research Initiative (with Bain & Company).,Pius Baschera is chair of entrepreneurship in the Department of Management
[3] Fotini Pachidou is a research associate at ETH Zurich.,undefined
[4] Technology and Economics,undefined
[5] ETH Zurich,undefined
[6] Zurich,undefined
[7] Switzerland.,undefined
来源
Nature Biotechnology | 2012年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Corporate venture funds are playing an increasingly important role in supporting life science commercialization.
引用
收藏
页码:911 / 915
页数:4
相关论文
共 50 条